A demethylating agent enhances chemosensitivity to vinblastine in a xenograft model of renal cell carcinoma

作者：Iwata Hiroki^*; Sato Hiromi; Suzuki Rina; Yamada Ryota; Ichinomiya Saki; Yanagihara Midori; Okabe Hiroyuki; Sekine Yuko; Yano Tomohiro; Ueno Koichi

来源：International Journal of Oncology, 2011, 38(6): 1653-1661.

DOI：10.3892/ijo.2011.999

• renal cancer
• 5-aza-2 '-deoxycytidine
• combined effect

Renal cell carcinoma (RCC) is resistant to chemotherapy partly due to the overexpression of the P-glycoprotein. Several tumor suppressor genes have been reported to be silenced by hypermethylation of the promoter region in RCC. We recently reported that the in vitro cytotoxicity of vinblastine (VBL) was enhanced by pre-treatment with the demethylating agent, 5-aza-2'-deoxycytidine (Aza), in the RCC cell line, Caki-1. In this study, we investigated the combined effect of Aza and VBL in a Caki-1 xenograft model and in other RCC cell lines in vitro. In the xenograft model, tumor volume and weight were significantly suppressed in the co-treatment group, compared to the control, and the expressions of P-glycoprotein, Bcl-2 and cycl in B1 were reduced. Thus, this combined effect could be mediated by the accumulation of intracellular VBL and the enhancement of apoptosis and cell cycle arrest. Moreover, the cytotoxicity of VBL was enhanced in vitro in three RCC cell lines by Aza treatment. These findings suggest that the combination treatment with Aza and VBL is effective against RCC.

• 出版日期2011-6